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Retroviruses As Genetic Tools to Isolate
Transcriptionally Active Chromosomal
Regions
by Harald von Melchner* and H. Earl Ruley*
By exploiting the ability of retroviruses to move genes into random sites of mammalian genomes and
by exploiting some features of their replication, retrovirus vectors have been developed that select for
instances in which the virus integrates into expressed genes. Since integrated proviruses tag transcrip-
tionally active sites, the vectors provide a means to identify and isolate promoters active in different cell
types. Furthermore, the viruses may be useful as insertional mutagens, since they select for instances in
which integration occurs into expressed sites. This reduces the number ofintegrants needed to screen for
loss of gene function and may enable genes controlling phenotypes in mammalian cells to be isolated.
Introduction
Like transposons in bacteria or retrotransposons in
lower eukaryotes (1-6), retroviruses are genetic ele-
ments capable of moving genes into the genomes of
mammalian cells. Upon integration, retroviruses may
cause either a recessive loss of gene function due to
gene disruption or a dominant gain of function due to
transcriptional activation of adjacent genes. Integra-
tions near cellular promoters or enhancers may also
activate viral gene expression.
By exploiting the ability of retroviruses to move
genes into random sites ofmammalian genomes and by
taking advantage of some features of their replication,
retrovirus vectors have been developed that select for
instances in which the virus integrates into expressed
genes (7,8). After briefly reviewing some aspects of re-
troviral replication, the present article discusses the
development and uses ofretrovirus vectors to tag tran-
scriptionally active chromosomal regions.
Replication of Retroviruses
Retroviruses are RNA viruses that replicate through
a DNA intermediate. Flanking the ends of the viral
genome are short sequence repeats (R) and unique se-
quences (U5 and U3) that control DNA synthesis, in-
tegration, transcription, and RNAprocessing. Between
the control regions are coding sequences for the major
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structural proteins of the virus particle (gag and env)
and for enzymes (pol) found in particles (protease, re-
verse transcriptase, and integrase) (2,9-11).
Shortly after infection, viral RNA is converted into
DNA by reverse transcriptase. Prior to integration,
terminal sequences of the viral genome join and are
duplicated such that the retroviral genome is flanked
by long terminal repeats (LTRs), each containing the
U3, R, and U5 regions. Circular forms ofthe viral gen-
ome, containing either one or two copies of the LTR,
are also found in virus-infected cells. There is evidence
that formation of circular molecules with two tandem
LTRs creates cis-acting recognition sequences for the
enzymes catalyzing integration. Thus, sequences con-
tainingaspleennecrosis virus LTR-LTRjunctionwhen
inserted into DNA at an internal site were sufficient to
promote integration. This suggests that circular gen-
omescontainingtwo LTRs canserve asintegration pre-
cursors (12,13). However, several investigators have
shown that, at least in vitro, linear viral DNA can in-
tegrate directly without forming a circularized inter-
mediate (14,15). The integration steps appearsimilarto
thoseobservedinE.coliduringphageMutransposition,
involving cleavage at the integration site; joining ofthe
retroviral 3' ends to protruding 5' ends of the target
DNA; andrepairofremainingsingle-stranded gaps(14).
Whether linear DNA also serves as an integration pre-
cursor in vivo remains to be established.
LTR sequences are maintained in the integrated re-
trovirus (also termed provirus) except that two nucleo-
tides (nt) are lost from each end (2,9,10). Cellular DNA
sequences are also unaltered except that upon integra-
tion, 4 to 6 nt are duplicated such that the provirus is
flanked at each end by 4 to 6 bp repeats (8,10,13).VON MELCHNER AND RULEY
As a provirus, the retroviral genome is replicated
with cellular DNA and transcribed as a cellular gene.
Provirus transcription is controlled by promoter/enhan-
cer sequences located in the U3 region of the 5' LTR.
Transcripts initiate at the junction between U3 and R
(cap site) in the 5' LTR and terminate at the R-U5
junction in the 3' LTR. RNA is synthesized by cellular
RNA polymerase II and processed by the cellular en-
zymes. Full-length (genomic) RNA is transported from
the nucleus to the cytoplasm and either packaged into
virus particles that bud from the cell or translated to
yield precursors ofthe gag and pol proteins. A fraction
of the RNA is spliced to yield mRNA encoding env.
It is possible to adaptretroviruses totransduce genes
into mammalian genomes. Provided that certain control
sequences within the LTRs remain unaltered (16,17),
much of the retroviral genome can be deleted without
impairing its ability to replicate in cells that express
proteins necessary for reverse transcription, integra-
tion, and particle formation. To do this, vector DNA is
transfected into cell lines that contain complete retro-
viral genomes. The helper virus cannot assemble into
particles due to asmall deletion thatremoves sequences
(termed T) required for assembly of viral RNA into
infectious virions. Since vector DNA does not contain
the T deletion, recombinant transcripts are packaged
and expelled from the cells as virus particles (Fig. 1).
In addition to NV, gag sequences also enhance the ability
of the vectors to be packaged (16,18-23).
Retroviruses appear to integrate randomly through-
out the genome, although about one-fifth ofall integra-
tions involve highly preferred sites (24). Integration
sometimes results in mutations that eitherinactivate or
augment expression ofgenes in the vicinity ofthe pro-
virus (9,25-27). Gene inactivation may be caused by
insertions into exons (28-30) that interrupt open read-
ing frames or introns (31,32) and alter normal splicing
patterns. Activation of genes adjacent to the provirus
involves transcriptional enhancement either by up-
stream U3 promoters ornearby U3 enhancers. By some
yet unknown mechanism, the activity of 3' LTRs is
inhibited by 5' LTRs (33). Thus, in most cases, where
downstream cellular genes are activated by 3' LTR pro-
moters, 5' LTRs are either rearranged or lost (34-40).
Development of a Retroviral
Promoter Trap
Transcriptional activation ofproviral genes has been
observed in cells in which the LTR is transcriptionally
inactive. In some instances activation was due to in-
sertions near cellular promoters or enhancers (41-44).
Thus, in principle it is possible to tag transcriptionally
active chromosomal regions by infecting cells with re-
trovirus vectors that contain a selectable marker (e.g.,
antibiotic resistance) or reporter gene (e.g., lacZ) and
selecting for recombinants in which the genes are ex-
pressed. However, several factors haveunderminedthe
practical use of retroviruses as probes for transcrip-
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FIGURE 1. Schematic representation ofa retrovirus packaging cell.
Shaded areas represent chromosomal flanking regions. v, virion;
rec, recombinant. Reprinted with permission (80).
tionally active chromosomal regions. First, enhancers
in the LTRs may influence the expression of adjacent
genes and thus interfere with the detection of cellular
sequences thatregulatetranscriptioninatissue-specific
manner (17,44-47). Second, 3' RNA processing signals
and AUGcodonswithinthelefthand LTR mayinterfere
with translation of proviral transcripts initiated by
nearby cellular promoters, since it has been shown that
AUG or termination codons upstream of the protein
synthesis initiating codon often inhibit efficient trans-
lation and lead toaberranttranslation products (48-52).
For these reasons, a retroviral vector aimed at detect-
ing cellular promoters should lack both enhancers and
viral sequences between proviral genes and flanking
DNA.
The strategy we have used (7,8) involved inserting a
selectable marker, histidinol dehydrogenase (hisD) (53)
into the 3' LTR of an enhancerless Moloney murine
leukemia virus (MoMuLV) (Fig. 2). The extra sequence
did not interfere with the ability ofthe virus to be pas-
saged and his sequences duplicated normally. Coding
sequences ofhisD in the 5' LTR were placedjust 30 nt
fromthe flankingcellular DNA (Fig. 3A). This removed
intervening viral sequences that could interfere with
transcriptional activation of provirus genes by cellular
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promoters. The virus also contained a second selectable
marker, neomycin-phosphotransferase (neo), expressed
from an internal herpes simplex virus thymidine kinase
(tk) promoter, to provide an independent measure of
virus infectivity (Fig. 2).
GgU3Hisen(-)
Nhe I KpnI BamH I Nhe I Nhe I KpnI
5 QM HIS-D
en-
0.5 kb
GgTKNeoU3Hisen(-)
Nhe I Kpn I BamH / BamH / Nhe I Nhe I Kpn I
EU3RUs Z gag grKI NEO HIS-D M"U
en-
FIGURE 2. Structures of recombinant retrovirus vectors. Gene se-
quences present in each virus are labeled as follows: HIS-D, Sal-
monellatyphimuriumhistidinol-dehydrogenase; NEO, neomycin-
phosphotransferase; gag, truncated gag region of MoMLV; and
TK, HSV thymidine kinase promotor. (en-) Designates a 178 nt
deletion inthe 3' LTRencompassingtheviralenhancer. Reprinted
with permission (7).
Virus-producing cell lines were generated by trans-
fectingU3HisvectorsintoNIH3T3celllinesexpressing
packaging-defective ecotropic (P2) and amphotropic
(PA317) helper viruses. Viruses recovered from cloned
producer lines were titered on NIH 3T3 cells, selecting
either with G418 (neomycin derivative) or L-histidinol.
Neo-titers of U3His viruses were high and similar to
what we and others have obtained with other MoMuLV
vectors (19,22,54-57), indicating that insertion of his
sequences into the LTR did not significantly interfere
with virus replication or integration. However, com-
paring the ratio of neomycin and histidinol titers sug-
gested that provirus integration was 2500-fold less
likely to convert cells to a histidinol-resistant (Hisr)
phenotype than to a neomycin resistant (Neor) pheno-
type.
In principle, the potential to express histidinol re-
sistance could be an intrinsic but inefficient property of
each provirus, or alternatively may require secondary
events such as mutations or transcriptional activation
by adjacent cellular sequences. Several experiments (7)
suggested that the capacity to transduce histidinol re-
sistance is neither an intrinsic property ofthe provirus
nor the consequence ofmutations: a) clones initially se-
lected in G418 did not survive when transferred to me-
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FIGURE 3. Analysis of proviral transcripts. (A) GgTKNeoU3Hisen(-) provirus structure, predicted transcripts, and sites of transcription
initiation in NeoR and His' clones. Total cellular RNA (10 p.g/lane) was extracted from Neol and His'clones, fractionated onformaldehyde/
agarose gels, transferred to nylon membranes, and hybridized to his (B) or neo (C) specific probes as follows: 1, 3, 5, 7, 9 are clones selected
in G418; 2, 4, 6, 8,10 are clones selected in L-histidinol. The sizes ofmajor RNA species as indicated were estimated from RNA standard
(BRL). Reprinted with permission (7).
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dium containing L-histidinol, indicating that most pro-
viruses did not confer histidinol resistance; b) the num-
ber of doubly resistant colonies produced after plating
U3His infected cells in medium containing both G418
and L-histidinol was similar to the number of colonies
obtained after selection in L-histidinol alone, implying
thatonly asubset oftheproviruses conferringneomycin
resistance was capable of expressing histidinol resist-
ance; c) virus titers were similar for U3His vectors with
or without tk promoters, indicating that the ability to
passage histidinol resistance did not require the tk pro-
motor; d) proviruses in Hisr clones lacked gross se-
quence rearrangements as judged by Southern blot
analysis; and e) proviruses rescued from Hisr clones
after superinfection with wild-type MoMuLV did not
transduce his any more efficiently (as compared with
neo) than did the original U3His vectors.
To further examine why only certain proviruses ex-
pressed his, transcription ofprovirus sequences in Hisr
and Neor clones was analyzed by Northern blot hybrid-
ization (Figs. 3A-C). The results indicated that the his-
tidinol-resistant phenotype is conferred by transcripts
initiating in the nearby provirus flanking region. Both
Neor and Hisr clones expressed 4.9- and 3.3-kbp pro-
virus transcripts, whereas only Hisr clones expressed
two additional transcripts of 6.5 and 1.7 kbp (Fig. 3B).
Mapping these RNAs according to their ability to hy-
bridize to his- and neo-specific probes (Figs. 3B and C)
suggested that the 4.9- and 3.3-kbp RNAs started at
the 5' LTR and at the tk promoter, respectively, and
terminated in the 3' LTR, whereas the 6.5- and 1.7-kb
RNAs in Hisr clones appeared to initiate outside the
provirus and terminate at polyadenylation sites in the
3' and 5' LTRs, respectively (Fig. 3A). The sizes ofthe
smaller (1.7 kbp) transcripts in Hisr clones were never
quite the same but varied as much as 100 bp (Fig. 3B).
This is the result one might expect if the proviruses
were located at different distances from cellular pro-
moters, and the size ofeach transcript depended on the
amount of appended cellular RNA.
It is ofinterest that the steady-state levels ofthe 3.3
kbp tkneohis mRNA were either undetectable or sig-
nificantly lower in Hisr clones than in Neor lines (Figs.
3B and C). Accordingly, Hisr clones exhibited variable
resistance to G418 ranging from 2 to 2 x 103 colony
forming units (CFU) per 105 cells (7). Although the
mechanisms are unknown, the phenomenon may reflect
suppression ofthe tk promoter by an upstream cellular
promoter. The phenomenon has been frequently ob-
served with retrovirus vectors (58-63) and was initially
described by Emermann and Temin (64,65). By using a
retrovirus vector that contained two marker genes un-
der the control of different promoters, these investi-
gators have shown that transcription ofthe 5' gene was
suppressed when there was selection for the 3' gene
and vice-versa, whereby the suppressed genes pro-
duced about 10to 50% lessproductthanwhenthey were
selected (65).
Ribonuclease protection assays confirmed that tran-
scripts conferring histidinol resistance are initiated in
the nearby flanking region. Accordingly, labeled RNA
probes complementary to the provirus coding strand
protected fragments of exactly the size expected for
transcripts colinear with provirus sequences extending
from the ClaI site to the 5' end of the LTR (Fig. 3A).
Thus, the ability of U3His viruses to convert cells to a
Hisr phenotype requires that the provirus acquire a
promoter from the flanking cellular DNA.
Severalinvestigators haveisolatedcellularpromoters
or enhancers by linking random DNA fragments to the
coding sequence ofa selectable marker, introducingthe
DNA into recipient cells and selecting for clones that
result if the gene is expressed (66-70). However, the
strategy has several limitations that the U3His vectors
avoid. First, DNA-mediated gene transfer is less effi-
cient than retrovirus transduction. Second, introduced
gens are frequently amplified in cells surviving selec-
tion, thus increasing background and necessitating
screening of multiple clones or performing secondary
transfections in order to identify clones containing only
one gene copy. Third, potential promoter-enhancer ele-
ments identified after DNA transfer are not expressed
in their normal chromosomal locations.
Transfected enhancerless genes have been used to
identify transcriptionally active chromosomal regions
(71-73). In some cases expression appeared to be reg-
ulated in a tissue-specific manner (71,73). However,
cloning the transcriptionally active genes by this ap-
proach is difficult because enhancers may be located at
considerable distance from and on either side of the
integrants (10).
Promoter Trap Vectors As Genetic
Tools to Isolate Cellular Promoters
The approach we employed to isolate cellular pro-
moters from U3His expressing cell lines involved the
polymerase chain reaction (PCR) (74-77). PCR allows
over 109 copies of a small segment of DNA to be made
by repeated cycles ofdenaturation, annealing ofspecific
oligonucleotide primers, primer extension, and chain
elongation by a thermostable DNA polymerase (Taq
polymerase). The standard technique requires oligon-
ucleotides complementary to sequences on opposite
strands and on each end of the DNA fragment to be
amplified. Although in U3His provirus expressing cell
lines genomic sequences are flanked only on one side by
a region of known sequence, it is possible to link both
ends of the flanking cellular DNA to the provirus. The
procedure involves digesting cellular DNA with an en-
zyme that generates small enough fragments to be am-
plified and ligatingthe DNAto obtaincircularmolecules
where both ends ofthe cellular DNA are flanked by the
provirus (Fig. 4A) (78,79).
Synthetic oligonucleotide primers complementary to
sequences on both sides ofthe PvuII site at position 72
ofthe U3His provirus were constructed that would per-
mit extension reactions proceeding away from each
other(Fig. 4A). Togenerate smallrestrictionfragments
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FIGURE 4. Amplification of sequences flanking U3His proviruses. (A) Strategy used to generate templates to be amplified by the polymerase
chain reaction. (B) Ethidium bromide-stained gel showing the PCR products ofsix HisR cell lines. (C) Ethidium bromide-stained gel showing
PCR products from clones 2 and 5 (lanes 1 and 3, respectively) digested with HinfI (lanes 3 and 4, respectively). The sizes of the PCR
products as indicated were estimated from 1 kbp DNA ladder standard (BRL). Adapted from von Melchner et al. (8).
that amplify more efficiently, genomic DNA was di-
gested to completion with HinfI, yielding an average
fragment length of800 bp. ReligatingHintfI protruding
ends positioned 5' proviral flanking fragments between
the proviral priming sites. To avoid background PCR
products originating from circles formed at the 3' end
ofthe provirus, the DNA was digested with PvuII. As
shown in Figure 4A, this technique separates the prim-
ingsites ontodifferent DNAfragments, thusprecluding
their geometric amplification. Such separation is less
likely to occur at the left (5') end because PvuII sites
are an order magnitude less frequent than HinfI sites
in mammalian DNA.
PCR products fromhistidinol-resistant lines were dif-
ferent in size, as one might expect ifthe proviruses are
located at different distances from a flankingHinfI site
and the size of each segment depends on the amount of
appended cellular DNA (Fig. 4B). In each case the am-
A
v.v.
_w
.: .. :. .:.:
*: .. ... .. .: ..
o. .....
..
:: :. i
R
145
Aw...t-VU.u
wth PVUVON MELCHNER AND RULEY
plified template represented the provirus-flanking re-
gion junction segment, extending between the two
HinfI sites. Thus, HinfI digestion yielded two frag-
ments: a 560 bp fragment representing the proviral re-
gion extending between the PvuII and HinfI sites and
a 100to500bpfragmentrepresentingthevariableflank-
ing sequence appended to the provirus region upstream
of the PvuII site (Fig. 4C) (8). In some instances, be-
cause of multiple proviral integrations, more than one
amplification product was observed (Fig. 4A). Several
clones exhibited a 680 bp minor band reflecting ampli-
fication of a few circular molecules from the 3' end of
the provirus (Fig. 4B). As the amplified flanking se-
quences contained between 100 to 500 nt, some are
likely to contain promoter elements. These sequences
have been cloned into Bluescript vectors for further
analysis.
U31acZ Vectors As Genetic Tools to
Analyze Patterns of Gene Regulation
Although U3His vectors provide a means to isolate
promoters active in different cell types, the vectors se-
lect for promoters that express his at levels sufficient
to confer resistance. This precludes detection of pro-
moters inactive in the target cells. For these reasons,
it seemed important to develop a vector that carries a
reporter gene instead ofa selectable markerin U3. The
strategy involved replacing his-D sequences in U3 of
GgTKNeoHisU3en(-) by the E. coli lacZ gene, a re-
porter gene whose expression is monitored by histo-
chemical staining. The obtained GgTKNeoU31acZen(-)
vector was transfected into T2 producer cells and the
viruses recovered from cloned producerlines titered on
NIH 3T3 cells by selecting in G418. Titers of Gg-
TKNeoU31acZen(-) were high and similar to U3His ti-
ters, indicatingthatthe insertion ofthe 3kbp lacZ gene
into the LTR did not interfere with virus replication or
integration (S. Reddy, H. von Melchner, and H. Ruley,
in preparation). Southern blot analysis of several
U31acZ infected NIH 3T3 clones revealed that the elon-
gated LTR can duplicate, thus placing lacZ sequences
30 nt downstream of the flanking cellular DNA (S.
Reddy, H. vonMelchner, and H. Ruley, inpreparation).
Approximately 0.5% ofNeo clones will express lacZ on
transcriptsinitiatinginflankingcellularsequences, sug-
gesting that U31acZ vectors may be used to isolate pro-
moters regulated during different stages ofcellular de-
velopment.
U3His Vectors As Insertional Mutagens
Because selection for U3His expression reduces the
size ofthe integration target to genomic sequences im-
mediately downstream of cellular promoters, U3His
vectors maybe effectiveinsertionalmutagens. Itis pos-
sible to estimate the maximum number of integration
sites that enable NIH 3T3 cells to express histidinol
resistance. The total integration target for neo trans-
duction cannot exceed the size ofthe genome (3 x 109
bp), implying that the integration target for his is ap-
proximately 106 nt. Integrations that activate his are
also likely to occur near transcriptional start sites to
avoid appending AUG codons upstream of his coding
sequences. In genes, the distance from the transcrip-
tional start site to the first AUG averages 50 to 100 nt
(50). Dividing the maximum integration target by the
size of the average integration site yields a maximum
of 1 x 104 to 2 x 104 integration sites capable of ex-
pressing his at levels sufficient to confer resistance.
Although this calculation probably overestimates the
number of integration sites, the value is still small
enough to suggest that U3His vectors may be used as
insertional mutagens. Thus, the provirus would serve
as a molecular tag to clone any gene whose function is
linked to an observable phenotype, assuming that the
gene is expressed at levels sufficient to promote histi-
dinol resistance. Cells derived from a collection of 104
to 105independentHisrclonesshouldcontainproviruses
in all expressed sites including transcriptionally active
genes. Consequently, selection for Hisr cell populations
should reduce the number of integrants needed to
screen for the loss ofgene function. Isolation of clones
expressing null phentotypes may be improved by the
use ofhypodiploid cells (e.g., CHO) and in cases where
gene inactivation yields a selectable phenotype (e.g.,
tumor suppressing genes or antioncogenes). Alterna-
tively, homozygous loss ofgene function may be accom-
plished by breedingmice derived from embryonal stem
cells infected with U3His vectors and that contain germ
line integrations ofthe provirus.
Conclusions
By tagging transcriptionally active genes, promoter
trapvectorsprovide ameanstoisolatepromotersactive
indifferentcelltypes. WhileU3Hisvirusesmaybeused
to identify and clone genes that are differentially ex-
pressed in cells generating observable phenotypes dur-
ing development (e.g., embryonal or hemopoietic stem
cells), U31acZ vectors may reveal, in addition, patterns
ofgeneregulationthataccompanyalterationsincellular
phenotypes (e.g., differentiation ormalignant transfor-
mation). Sequences flanking the 5' ends of his or lacZ
expressing proviruses may be amplified by the poly-
merase chain reaction cloned, and used as probes to
isolate cDNA clones derived from transcripts ofgenes
expressed during distinct stages of cellular develop-
ment.
Finally, U3His vectors may make effective inser-
tional mutagens because they select for instances in
which integration occurs into expressed sites. This re-
duces the number of integrants needed to screen for
loss of gene function and may enable genes controlling
phenotypes in mammalian cells to be isolated.
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